Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
BridgeBio Oncology Therapeutics, Inc. has filed 173 SEC EDGAR filings since 20 Dec 2023

SEC filing history

Showing 126-150 of 173 matching filings.

Per page
25
Current page
6
10-K File 001-41955

ANNUAL REPORT

Filing date
11 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
425 File 001-41955

FORM 425

Filing date
06 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13D/A File 005-94447

SCHEDULE 13D/A filing

Filing date
04 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-41955

CURRENT REPORT

Filing date
03 Mar 2025
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
03 Mar 2025
Reporting date
28 Feb 2025
Next action
Verify source filing
425 File 001-41955

CURRENT REPORT

Filing date
28 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
28 Feb 2025
Reporting date
28 Feb 2025
Next action
Verify source filing
3

3 filing

Filing date
11 Feb 2025
Reporting date
08 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
08 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Feb 2025
Reporting date
08 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
10 Feb 2025
Reporting date
08 Feb 2025
Next action
Verify source filing
10-Q File 001-41955

QUARTERLY REPORT

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13G File 005-94447

SC 13G filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94447

SC 13G filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94447

SC 13G filing

Filing date
22 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-41955

QUARTERLY REPORT

Filing date
14 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-Q File 001-41955

QUARTERLY REPORT

Filing date
15 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
SC 13G File 005-94447

HELIX ACQUISITION CORP. II

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94447

SC 13G

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-94447

SCHEDULE 13D

Filing date
20 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
20 Feb 2024
Reporting date
13 Feb 2024
Next action
Verify source filing
SC 13G File 005-94447

SC 13G filing

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41955

CURRENT REPORT

Filing date
14 Feb 2024
Reporting date
08 Feb 2024
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
13 Feb 2024
Reporting date
13 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .